KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Short-term Investments (2020 - 2025)

CareDx (CDNA) has disclosed Short-term Investments for 6 consecutive years, with $111.8 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments fell 23.42% to $111.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $111.8 million through Dec 2025, down 23.42% year-over-year, with the annual reading at $111.8 million for FY2025, 23.42% down from the prior year.
  • Short-term Investments hit $111.8 million in Q4 2025 for CareDx, up from $102.8 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $211.3 million in Q1 2023 to a low of $10.2 million in Q3 2021.
  • Historically, Short-term Investments has averaged $135.9 million across 5 years, with a median of $142.2 million in 2025.
  • Biggest five-year swings in Short-term Investments: surged 1942.52% in 2022 and later tumbled 41.96% in 2024.
  • Year by year, Short-term Investments stood at $10.2 million in 2021, then skyrocketed by 1892.04% to $203.2 million in 2022, then decreased by 24.58% to $153.2 million in 2023, then decreased by 4.74% to $146.0 million in 2024, then dropped by 23.42% to $111.8 million in 2025.
  • Business Quant data shows Short-term Investments for CDNA at $111.8 million in Q4 2025, $102.8 million in Q3 2025, and $118.0 million in Q2 2025.